Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caloric Restriction | 2 | 2019 | 93 | 0.850 |
Why?
|
| Exercise | 4 | 2019 | 559 | 0.760 |
Why?
|
| Obesity | 4 | 2019 | 1068 | 0.700 |
Why?
|
| Geriatric Assessment | 10 | 2016 | 343 | 0.530 |
Why?
|
| Gene Expression | 2 | 2006 | 329 | 0.520 |
Why?
|
| Disability Evaluation | 4 | 2019 | 228 | 0.520 |
Why?
|
| Aged | 28 | 2019 | 9677 | 0.490 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 1039 | 0.460 |
Why?
|
| Aging | 8 | 2016 | 891 | 0.450 |
Why?
|
| Lung | 1 | 2013 | 231 | 0.430 |
Why?
|
| Female | 36 | 2019 | 18453 | 0.420 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 165 | 0.400 |
Why?
|
| Women's Health | 3 | 2016 | 218 | 0.380 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 338 | 0.370 |
Why?
|
| Motor Activity | 4 | 2016 | 321 | 0.360 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 879 | 0.340 |
Why?
|
| Morphogenesis | 1 | 2008 | 9 | 0.340 |
Why?
|
| Male | 32 | 2019 | 18231 | 0.340 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 64 | 0.330 |
Why?
|
| Drosophila melanogaster | 1 | 2008 | 39 | 0.330 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 44 | 0.330 |
Why?
|
| Humans | 36 | 2019 | 28999 | 0.320 |
Why?
|
| Oral Health | 4 | 2011 | 39 | 0.310 |
Why?
|
| Aged, 80 and over | 16 | 2017 | 3728 | 0.310 |
Why?
|
| Biometry | 1 | 2006 | 12 | 0.300 |
Why?
|
| Exercise Test | 3 | 2019 | 194 | 0.290 |
Why?
|
| Rural Population | 4 | 2012 | 290 | 0.290 |
Why?
|
| Computational Biology | 1 | 2005 | 86 | 0.280 |
Why?
|
| Exercise Therapy | 3 | 2019 | 209 | 0.260 |
Why?
|
| Exercise Tolerance | 2 | 2019 | 112 | 0.260 |
Why?
|
| Signal Transduction | 1 | 2008 | 688 | 0.250 |
Why?
|
| Tongue | 2 | 2012 | 12 | 0.220 |
Why?
|
| Laryngoscopy | 2 | 2011 | 35 | 0.210 |
Why?
|
| Deglutition | 2 | 2011 | 30 | 0.210 |
Why?
|
| Respiratory Aspiration | 2 | 2011 | 21 | 0.210 |
Why?
|
| Time Factors | 8 | 2011 | 2030 | 0.200 |
Why?
|
| Prospective Studies | 7 | 2016 | 1989 | 0.200 |
Why?
|
| Physical Fitness | 2 | 2012 | 116 | 0.190 |
Why?
|
| Middle Aged | 19 | 2019 | 11242 | 0.190 |
Why?
|
| Body Mass Index | 3 | 2019 | 880 | 0.190 |
Why?
|
| Age Factors | 6 | 2012 | 1129 | 0.180 |
Why?
|
| Fatigue | 1 | 2019 | 72 | 0.180 |
Why?
|
| Risk Factors | 6 | 2018 | 3569 | 0.180 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 138 | 0.180 |
Why?
|
| Hand Strength | 4 | 2012 | 88 | 0.180 |
Why?
|
| Quality of Life | 6 | 2016 | 854 | 0.170 |
Why?
|
| Diet | 2 | 2011 | 345 | 0.170 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 713 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 781 | 0.170 |
Why?
|
| United States | 5 | 2018 | 3700 | 0.160 |
Why?
|
| Cause of Death | 1 | 2018 | 222 | 0.160 |
Why?
|
| Inflammation | 2 | 2012 | 498 | 0.160 |
Why?
|
| Incidence | 2 | 2018 | 1097 | 0.150 |
Why?
|
| Deglutition Disorders | 3 | 2011 | 49 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2019 | 483 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 477 | 0.150 |
Why?
|
| Genes, Fungal | 2 | 2006 | 4 | 0.150 |
Why?
|
| Regression Analysis | 2 | 2008 | 289 | 0.150 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 722 | 0.150 |
Why?
|
| Independent Living | 1 | 2016 | 60 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2008 | 206 | 0.140 |
Why?
|
| Diet Surveys | 3 | 2011 | 64 | 0.140 |
Why?
|
| Cell Cycle | 2 | 2006 | 73 | 0.140 |
Why?
|
| Patient Dropouts | 1 | 2015 | 24 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2018 | 1319 | 0.140 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 142 | 0.140 |
Why?
|
| Cross-Sectional Studies | 7 | 2012 | 1352 | 0.140 |
Why?
|
| Models, Statistical | 2 | 2006 | 159 | 0.140 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 236 | 0.130 |
Why?
|
| Mobility Limitation | 1 | 2016 | 181 | 0.130 |
Why?
|
| Resistance Training | 1 | 2015 | 68 | 0.130 |
Why?
|
| Microarray Analysis | 2 | 2012 | 19 | 0.130 |
Why?
|
| Survivors | 1 | 2016 | 152 | 0.130 |
Why?
|
| Weight Loss | 2 | 2014 | 405 | 0.130 |
Why?
|
| Behavior Therapy | 1 | 2014 | 89 | 0.130 |
Why?
|
| Animals | 6 | 2012 | 7360 | 0.130 |
Why?
|
| Movement | 1 | 2014 | 34 | 0.130 |
Why?
|
| Algorithms | 2 | 2008 | 460 | 0.120 |
Why?
|
| Cluster Analysis | 2 | 2010 | 123 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2016 | 676 | 0.120 |
Why?
|
| Motor Cortex | 2 | 2014 | 11 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2015 | 207 | 0.120 |
Why?
|
| Food | 2 | 2011 | 45 | 0.120 |
Why?
|
| Bacterial Translocation | 1 | 2012 | 8 | 0.120 |
Why?
|
| Acute-Phase Proteins | 1 | 2012 | 11 | 0.120 |
Why?
|
| Overweight | 1 | 2014 | 256 | 0.120 |
Why?
|
| Arthritis, Experimental | 1 | 2012 | 4 | 0.110 |
Why?
|
| Life Style | 1 | 2014 | 368 | 0.110 |
Why?
|
| Dental Health Services | 1 | 2012 | 11 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 103 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 96 | 0.110 |
Why?
|
| Gastrointestinal Transit | 1 | 2011 | 7 | 0.110 |
Why?
|
| Hypocalcemia | 1 | 2011 | 8 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2012 | 114 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2011 | 59 | 0.110 |
Why?
|
| Thyroidectomy | 1 | 2011 | 14 | 0.110 |
Why?
|
| Cohort Studies | 5 | 2016 | 1694 | 0.110 |
Why?
|
| Parathyroid Hormone | 1 | 2011 | 40 | 0.110 |
Why?
|
| Infant Welfare | 1 | 2011 | 3 | 0.110 |
Why?
|
| Phonation | 1 | 2011 | 1 | 0.110 |
Why?
|
| Maternal Welfare | 1 | 2011 | 5 | 0.110 |
Why?
|
| Depression, Postpartum | 1 | 2011 | 9 | 0.110 |
Why?
|
| Mother-Child Relations | 1 | 2011 | 16 | 0.110 |
Why?
|
| Osteoarthritis | 1 | 2012 | 68 | 0.110 |
Why?
|
| Muscle Strength | 1 | 2012 | 130 | 0.110 |
Why?
|
| Cytokines | 1 | 2012 | 240 | 0.100 |
Why?
|
| Xerostomia | 1 | 2011 | 30 | 0.100 |
Why?
|
| Cognition | 2 | 2019 | 529 | 0.100 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2010 | 8 | 0.100 |
Why?
|
| Stroke | 2 | 2014 | 556 | 0.100 |
Why?
|
| Adiposity | 1 | 2012 | 198 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2009 | 118 | 0.100 |
Why?
|
| Biostatistics | 1 | 2010 | 9 | 0.100 |
Why?
|
| Stomatognathic Diseases | 1 | 2010 | 6 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 1 | 2010 | 24 | 0.100 |
Why?
|
| Social Support | 1 | 2011 | 161 | 0.100 |
Why?
|
| Sex Factors | 4 | 2017 | 652 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2010 | 39 | 0.100 |
Why?
|
| Food Preferences | 1 | 2010 | 39 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2010 | 59 | 0.100 |
Why?
|
| Bicycling | 1 | 2009 | 12 | 0.100 |
Why?
|
| Cardiac Output | 1 | 2009 | 31 | 0.100 |
Why?
|
| Mouth, Edentulous | 1 | 2009 | 4 | 0.100 |
Why?
|
| Acetabulum | 1 | 2010 | 30 | 0.100 |
Why?
|
| Nutrition Disorders | 1 | 2009 | 15 | 0.100 |
Why?
|
| Dental Care for Aged | 1 | 2009 | 7 | 0.090 |
Why?
|
| Oral Hygiene | 1 | 2009 | 18 | 0.090 |
Why?
|
| Health Surveys | 3 | 2016 | 200 | 0.090 |
Why?
|
| Probability | 2 | 2009 | 152 | 0.090 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2010 | 46 | 0.090 |
Why?
|
| Heart Failure, Diastolic | 1 | 2009 | 16 | 0.090 |
Why?
|
| Neoplasms | 1 | 2016 | 644 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2009 | 71 | 0.090 |
Why?
|
| Sepsis | 1 | 2010 | 138 | 0.090 |
Why?
|
| Lower Extremity | 1 | 2009 | 85 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2010 | 165 | 0.090 |
Why?
|
| Capillaries | 1 | 2008 | 22 | 0.090 |
Why?
|
| Geriatrics | 1 | 2010 | 97 | 0.090 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 155 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2010 | 164 | 0.090 |
Why?
|
| Quadriceps Muscle | 1 | 2008 | 30 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 2147 | 0.090 |
Why?
|
| Nutrition Surveys | 1 | 2009 | 134 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2010 | 145 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2010 | 422 | 0.080 |
Why?
|
| Health Status | 3 | 2016 | 381 | 0.080 |
Why?
|
| Models, Animal | 1 | 2008 | 165 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 106 | 0.080 |
Why?
|
| Health Behavior | 1 | 2009 | 230 | 0.080 |
Why?
|
| Comorbidity | 1 | 2009 | 557 | 0.080 |
Why?
|
| Macaca fascicularis | 1 | 2008 | 389 | 0.080 |
Why?
|
| Dementia | 1 | 2009 | 212 | 0.080 |
Why?
|
| Genes, Insect | 1 | 2006 | 4 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2006 | 12 | 0.080 |
Why?
|
| Least-Squares Analysis | 1 | 2006 | 30 | 0.080 |
Why?
|
| Dictyostelium | 1 | 2005 | 1 | 0.070 |
Why?
|
| Fungal Proteins | 1 | 2005 | 5 | 0.070 |
Why?
|
| Normal Distribution | 1 | 2005 | 10 | 0.070 |
Why?
|
| Stochastic Processes | 1 | 2005 | 6 | 0.070 |
Why?
|
| Ethanol | 1 | 2008 | 181 | 0.070 |
Why?
|
| Drosophila | 1 | 2006 | 37 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 230 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2006 | 103 | 0.070 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 62 | 0.070 |
Why?
|
| North Carolina | 4 | 2012 | 1643 | 0.070 |
Why?
|
| Models, Biological | 1 | 2008 | 372 | 0.070 |
Why?
|
| Linear Models | 3 | 2012 | 433 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1534 | 0.070 |
Why?
|
| Software | 1 | 2005 | 110 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 667 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 350 | 0.070 |
Why?
|
| Heart Failure | 1 | 2009 | 576 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 583 | 0.060 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 239 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2016 | 470 | 0.060 |
Why?
|
| Hypertension | 1 | 2009 | 970 | 0.060 |
Why?
|
| Laryngoscopes | 2 | 2011 | 8 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2019 | 3149 | 0.050 |
Why?
|
| Reference Values | 2 | 2011 | 233 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2014 | 182 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 308 | 0.050 |
Why?
|
| Body Composition | 2 | 2014 | 359 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 524 | 0.050 |
Why?
|
| Logistic Models | 2 | 2012 | 758 | 0.050 |
Why?
|
| European Continental Ancestry Group | 2 | 2017 | 1258 | 0.050 |
Why?
|
| Executive Function | 1 | 2019 | 55 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2011 | 575 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 709 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2010 | 419 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 388 | 0.040 |
Why?
|
| Lysine | 1 | 2017 | 20 | 0.040 |
Why?
|
| African Continental Ancestry Group | 1 | 2017 | 382 | 0.040 |
Why?
|
| Continental Population Groups | 1 | 2017 | 233 | 0.040 |
Why?
|
| Mice | 2 | 2012 | 2331 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 113 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2015 | 72 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 328 | 0.030 |
Why?
|
| Length of Stay | 1 | 2016 | 296 | 0.030 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2014 | 2 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 5 | 0.030 |
Why?
|
| Motor Skills | 1 | 2014 | 12 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2014 | 60 | 0.030 |
Why?
|
| Electromyography | 1 | 2014 | 52 | 0.030 |
Why?
|
| Health Education | 1 | 2014 | 131 | 0.030 |
Why?
|
| Young Adult | 2 | 2011 | 2409 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2014 | 90 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2014 | 52 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 98 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2014 | 135 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2011 | 3073 | 0.030 |
Why?
|
| Adolescent | 2 | 2011 | 3232 | 0.030 |
Why?
|
| Chemokine CCL21 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Stifle | 1 | 2012 | 3 | 0.030 |
Why?
|
| Interleukins | 1 | 2012 | 18 | 0.030 |
Why?
|
| Gait | 1 | 2012 | 92 | 0.030 |
Why?
|
| Esophageal Motility Disorders | 1 | 2011 | 5 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 45 | 0.030 |
Why?
|
| Viscosity | 1 | 2011 | 22 | 0.030 |
Why?
|
| Thyroid Diseases | 1 | 2011 | 6 | 0.030 |
Why?
|
| Tibia | 1 | 2012 | 50 | 0.030 |
Why?
|
| Hindlimb | 1 | 2012 | 57 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 2012 | 61 | 0.030 |
Why?
|
| ROC Curve | 1 | 2011 | 152 | 0.030 |
Why?
|
| Beverages | 1 | 2011 | 20 | 0.030 |
Why?
|
| Indians, North American | 1 | 2011 | 141 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 2011 | 39 | 0.030 |
Why?
|
| Poly I-C | 1 | 2010 | 4 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 11 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2011 | 107 | 0.030 |
Why?
|
| Psychometrics | 1 | 2011 | 134 | 0.030 |
Why?
|
| Educational Status | 1 | 2011 | 164 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2010 | 55 | 0.020 |
Why?
|
| Poverty | 1 | 2011 | 99 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2010 | 76 | 0.020 |
Why?
|
| Gestational Age | 1 | 2010 | 97 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 175 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2010 | 67 | 0.020 |
Why?
|
| Rural Health | 1 | 2010 | 59 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 227 | 0.020 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2010 | 10 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 298 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 85 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 475 | 0.020 |
Why?
|
| Iliac Artery | 1 | 2009 | 47 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2009 | 44 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 301 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 46 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2009 | 29 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 75 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2009 | 112 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2010 | 74 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2008 | 10 | 0.020 |
Why?
|
| Wound Healing | 1 | 2010 | 180 | 0.020 |
Why?
|
| Research Design | 1 | 2010 | 281 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 744 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 784 | 0.020 |
Why?
|
| Walking | 1 | 2009 | 168 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 203 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 912 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 308 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 227 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2009 | 166 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 936 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 198 | 0.020 |
Why?
|
| Adult | 2 | 2011 | 8644 | 0.020 |
Why?
|
| Smoking | 1 | 2011 | 438 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 387 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 228 | 0.020 |
Why?
|
| Self Administration | 1 | 2008 | 296 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 278 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2009 | 927 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 890 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 493 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 1210 | 0.020 |
Why?
|
| Child | 1 | 2010 | 2130 | 0.020 |
Why?
|
| African Americans | 1 | 2011 | 1571 | 0.020 |
Why?
|